Ruggie Capital Group Has $2.20 Million Stock Holdings in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Ruggie Capital Group grew its stake in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 15.6% in the second quarter, according to its most recent filing with the SEC. The institutional investor owned 20,176 shares of the financial services provider’s stock after purchasing an additional 2,716 shares during the period. iShares Nasdaq Biotechnology ETF comprises approximately 3.7% of Ruggie Capital Group’s portfolio, making the stock its 7th biggest position. Ruggie Capital Group’s holdings in iShares Nasdaq Biotechnology ETF were worth $2,201,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently modified their holdings of IBB. Global Trust Asset Management LLC grew its holdings in shares of iShares Nasdaq Biotechnology ETF by 89,733.3% in the second quarter. Global Trust Asset Management LLC now owns 32,340 shares of the financial services provider’s stock valued at $32,000 after acquiring an additional 32,304 shares in the last quarter. Trustcore Financial Services LLC bought a new position in shares of iShares Nasdaq Biotechnology ETF in the first quarter valued at approximately $34,000. Meridian Wealth Management LLC bought a new position in shares of iShares Nasdaq Biotechnology ETF in the first quarter valued at approximately $36,000. Signaturefd LLC grew its holdings in shares of iShares Nasdaq Biotechnology ETF by 59.2% in the second quarter. Signaturefd LLC now owns 328 shares of the financial services provider’s stock valued at $36,000 after acquiring an additional 122 shares in the last quarter. Finally, Destination Wealth Management bought a new position in shares of iShares Nasdaq Biotechnology ETF in the first quarter valued at approximately $42,000. 74.36% of the stock is owned by hedge funds and other institutional investors.

Shares of IBB stock traded up $1.02 during trading on Wednesday, hitting $106.10. The company’s stock had a trading volume of 84,897 shares, compared to its average volume of 2,652,543. The business has a fifty day moving average of $105.88 and a 200-day moving average of $107.64. iShares Nasdaq Biotechnology ETF has a 52 week low of $89.01 and a 52 week high of $122.97.

About iShares Nasdaq Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Further Reading: If I purchase shares through a brokerage account, am I the holder of record?

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.